In NSCLC, RET copy number gains (8.1%) and amplifications (2.8%; when defined as innumerable RET clusters, or ≥7 copies in >10% of tumor cells) are detected in a higher proportion of tumor samples when compared to RET rearrangements (0.7%) [87]. Here, RET is linked to non-small cell lung carcinoma.